The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
about
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazideEffect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and femalesPharmacokinetic interactions of drugs with St John's wort.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management.Use of herbal products and potential interactions in patients with cardiovascular diseasesResveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.Herbal modulation of P-glycoprotein.Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.Complementary and alternative medications in hepatitis C infection.In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesPerioperative use of herbal, complementary, and over the counter medicines in plastic surgery patientsComplex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavirDose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamicsHerb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.The effect of food components on the absorption of P-gp substrates: a review.Complex drug interactions of HIV protease inhibitors 2: in vivo induction and in vitro to in vivo correlation of induction of cytochrome P450 1A2, 2B6, and 2C9 by ritonavir or nelfinavir.Interaction of St John's wort with conventional drugs: systematic review of clinical trials."Cocktail" approaches and strategies in drug development: valuable tool or flawed science?Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaDrug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsThe effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards.Natural health product interactions with medication.Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?The recovery time-course of CYP3A after induction by St John's wort administration.Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms.Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics.Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature.Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.Drug interaction between St John's Wort and quazepam.Effect of soy extract administration on losartan pharmacokinetics in healthy female volunteers.Drug interaction between St John's wort and zolpidem in healthy subjects.Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.
P2860
Q24651117-94C07878-7433-40C9-817F-F773608D9EA9Q24679237-1AC58424-6F03-4975-8B0A-A03FE21485ABQ33204911-5504D0DD-EA56-46BA-B250-FAB3D15118B9Q33509452-8A00ADE5-124F-4D95-9B24-3CA35F584EBCQ33604138-36281588-7BAA-4F43-9D6D-A448DAEFBAE1Q33701372-0B71C114-F982-4611-812B-746F726CBD37Q34103899-180C0845-AD70-47FD-92DC-78581B58AC7EQ34185982-A2802E72-B75F-485E-99F0-75E76F23BBACQ34312035-4D3579E9-6FF6-4908-B9C7-1464695C2B85Q34360600-BFC6BFD1-E42D-44E3-BF8A-4C077591CFABQ34411345-3A28E714-365B-4243-92EA-6FE98388B46EQ34419646-534FF840-B801-4998-A575-FDCFF48AC1CCQ34994681-0222A84B-01A6-4BF0-85DF-83536AEC48E5Q35002453-7426FE15-B24D-49F9-9D71-6ED2894A8965Q35003666-0970EF1C-EDFF-41C9-A9AB-54D44FE801FEQ35009679-8DABE318-5CB8-43A4-9A5C-498C5546E3C5Q35083696-BD8D559B-65F0-428E-B420-2D4AAC633FB1Q35579558-5FF94A62-7B5A-480D-BC75-EC9887F6AA4AQ35615173-9A90EAC6-EAF7-4C59-8649-C829654EC5AEQ35640730-615755CD-442D-4394-8F07-E868E2B592F6Q35725540-A479B49C-4582-4FDE-BA7F-A4A593384D05Q35765836-42692C34-CDE6-4C2A-BBB0-DB2D47093DC3Q35774851-37FD241F-6F9C-4F1D-AD77-33A0A9CB5960Q35826093-F38B496F-8EA8-4A43-B07C-AEEA05FBBE3EQ35827865-B42108BD-867B-4614-9509-268276683FBDQ36024644-E94F12BF-1041-4EE2-A945-7D15FFA477CAQ36278312-8650823B-9BAA-4149-B848-F9CF332ABEDAQ36502919-35924A7D-9979-46A1-B83B-307ED28CA1B1Q36581240-B5D01981-2A50-4433-A156-CA5E60485941Q36729151-C67FC8BD-3B65-40FB-9D27-785C8E42E3EEQ36926307-B3A10C28-5A09-4644-92B6-8D702852EB08Q37124261-7248D11F-FA45-4C09-915A-E1BE461FEFBBQ37184013-0332A963-C644-4599-9700-4A3AC9CAD517Q38258277-3B3DA173-AFA1-420D-8C35-6D347C16CA6DQ38836954-AD91EDBF-058F-4743-A08A-1B7A3CE04B7DQ40330877-6C9D1B3D-1201-47FD-B6E6-EC86AE160208Q42158860-F9FB3D8F-5BAB-4AFE-B991-DEC4BB06CE14Q42621840-3F409986-2947-42DC-9480-86476DDDA243Q42681226-7DE399E6-1684-4FBE-8DC6-5BC2FC15E7EBQ42876694-21EAF142-3454-48D5-902B-496914D3EBC9
P2860
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
@en
The effects of St John's wort
@nl
type
label
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
@en
The effects of St John's wort
@nl
prefLabel
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
@en
The effects of St John's wort
@nl
P2093
P1476
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
@en
P2093
P304
P356
10.1016/S0009-9236(01)17221-8
P407
P577
2001-10-01T00:00:00Z